Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48,041,653
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
7,525,099
-
Shares change
-
-175,821
-
Total reported value, excl. options
-
$90,520,000
-
Value change
-
-$6,348,673
-
Number of buys
-
31
-
Number of sells
-
-25
-
Price
-
$12.03
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q4 2018
65 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q4 2018.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,525,099 shares
of 48,041,653 outstanding shares and own 16% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (2,428,571 shares), SANDLER CAPITAL MANAGEMENT (968,073 shares), Vanguard Group Inc (557,268 shares), RENAISSANCE TECHNOLOGIES LLC (443,500 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (434,127 shares), Schonfeld Strategic Advisors LLC (336,700 shares), ESSEX INVESTMENT MANAGEMENT CO LLC (308,185 shares), CADENCE CAPITAL MANAGEMENT LLC (191,830 shares), First Eagle Investment Management, LLC (177,578 shares), and BlackRock Inc. (152,878 shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.